Kaliumklorid-Glukose Sad (Potassium Chloride, Glucose Monohydrate)

Potassium chloride supplies potassium ions that raise serum potassium levels, while glucose monohydrate provides a rapid source of carbohydrate that stimulates insulin release. Insulin promotes the movement of potassium into cells, helping to normalize electrolyte balance and supply cellular energy.

The dose of Kaliumklorid-Glukose Sad is individualized by the prescribing clinician based on the patient’s serum potassium, glucose levels, weight, renal function and overall clinical condition. No fixed regimen is provided; the prescriber determines the appropriate infusion rate and volume.

Safety data for Kaliumklorid-Glukose Sad in pregnancy and lactation are limited. It should only be used when the potential benefit to the mother outweighs any possible risk to the fetus or infant, and under close medical supervision.

To order, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain needs) and import documentation.

Kaliumklorid-Glukose Sad combines potassium chloride with glucose, offering both potassium repletion and an immediate energy source. Compared with plain potassium chloride solutions, it may reduce the risk of hypoglycemia and facilitate intracellular potassium shift, while still providing the same electrolyte correction benefits.

Store Kaliumklorid-Glukose Sad at ambient temperature, preferably below 25 °C. Keep the container sealed, protect it from direct light and moisture, and avoid freezing. Follow standard aseptic handling procedures when preparing the IV infusion.

The product is administered intravenously. It is typically diluted in compatible IV fluids and infused over a period determined by the prescriber, with continuous monitoring of serum potassium, glucose, and cardiac rhythm as appropriate.

Serious risks include severe hyperkalemia leading to cardiac arrhythmia, anaphylactic reactions, and rapid shifts in blood glucose that may cause metabolic disturbances. Immediate medical attention is required if signs of cardiac irregularities, severe allergic response, or unexpected blood‑sugar changes occur.

Patients with known hypersensitivity to potassium chloride or glucose monohydrate, those with severe hyperkalemia, uncontrolled diabetes with high baseline glucose, or severe renal failure where potassium excretion is compromised should not receive this product unless closely monitored by a specialist.